Cargando…
Humoral and cellular immune response levels at a 1-year follow-up after mild COVID-19
The primary objective of this study was to establish a 1-year follow-up of patients after mild COVID-19 with no or only short-term detection of antibodies shortly after disease. At 1 year after disease, cellular memory against SARS-CoV-2, as measured by IFN-γ release by T cells, was detected in 76%...
Autores principales: | Flieder, Tobias, Fischer, Bastian, von Bargen, Katharina, Peter, Andreas, Knabbe, Cornelius, Birschmann, Ingvild |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262650/ https://www.ncbi.nlm.nih.gov/pubmed/35896052 http://dx.doi.org/10.1016/j.jcv.2022.105236 |
Ejemplares similares
-
Retrospective analysis of 426 donors of a convalescent collective after mild COVID-19
por: Flieder, Tobias, et al.
Publicado: (2021) -
Evidence of Long-Lasting Humoral and Cellular Immunity against SARS-CoV-2 Even in Elderly COVID-19 Convalescents Showing a Mild to Moderate Disease Progression
por: Fischer, Bastian, et al.
Publicado: (2021) -
Retrospective study shows that early administration of convalescent plasma in hospitalized COVID‐19 patients may have a positive effect on disease progression
por: Birschmann, Ingvild, et al.
Publicado: (2022) -
UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and Its Comparison with Functional Assays
por: Kuhn, Joachim, et al.
Publicado: (2015) -
The Sysmex CS-5100 coagulation analyzer offers comparable analytical performance and excellent throughput capabilities
por: Flieder, T., et al.
Publicado: (2016)